Evidence map›Paper›PMID 36354319›Full record

ArticleMicrobiology spectrum2022

Global Downregulation of Penicillin Resistance and Biofilm Formation by MRSA Is Associated with the Interaction between Kaempferol Rhamnosides and Quercetin.

Xinlong He, Wenwen Zhang, Qingchao Cao, Yinyue Li, Guangyu Bao, Tao Lin, Jiaojiao Bao, Caiwang Chang, Changshui Yang, Yi Yin and 4 more

Open access · goldAbstract read
In one paragraph

Article in Microbiology spectrum, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

Xinlong He *Department of Pathogenic Biology, School of Medicine, Yangzhou Universitygrid.268415.c, Yangzhou, People's Republic of China.ORCID 0000-0003-2894-8250
Wenwen Zhang *Department of Pathogenic Biology, School of Medicine, Yangzhou Universitygrid.268415.c, Yangzhou, People's Republic of China.
Qingchao Cao *College of Bioscience and Biotechnology, Yangzhou Universitygrid.268415.c, Yangzhou, People's Republic of China.
Yinyue LiDepartment of Pathogenic Biology, School of Medicine, Yangzhou Universitygrid.268415.c, Yangzhou, People's Republic of China.
Guangyu BaoAffiliated Hospital of Yangzhou Universitygrid.268415.c, Yangzhou, People's Republic of China.
Tao LinAffiliated Hospital of Yangzhou Universitygrid.268415.c, Yangzhou, People's Republic of China.
Jiaojiao BaoAffiliated Hospital of Yangzhou Universitygrid.268415.c, Yangzhou, People's Republic of China.
Caiwang ChangAffiliated Hospital of Yangzhou Universitygrid.268415.c, Yangzhou, People's Republic of China.
Changshui YangDepartment of Pharmacy, School of Medicine, Yangzhou Universitygrid.268415.c, Yangzhou, People's Republic of China.
Yi YinDepartment of Pathogenic Biology, School of Medicine, Yangzhou Universitygrid.268415.c, Yangzhou, People's Republic of China.
Jiahui XuDepartment of Pathogenic Biology, School of Medicine, Yangzhou Universitygrid.268415.c, Yangzhou, People's Republic of China.
Zhenyu RenDepartment of Pathogenic Biology, School of Medicine, Yangzhou Universitygrid.268415.c, Yangzhou, People's Republic of China.
Yingshan JinCollege of Bioscience and Biotechnology, Yangzhou Universitygrid.268415.c, Yangzhou, People's Republic of China.
Feng LuDepartment of Pathogenic Biology, School of Medicine, Yangzhou Universitygrid.268415.c, Yangzhou, People's Republic of China.
Yangzhou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The rapid development of methicillin-resistant Staphylococcus aureus (MRSA) drug resistance and the formation of biofilms seriously challenge the clinical application of classic antibiotics. Extracts of the traditional herb Chenopodium ambrosioides L. were found to have strong antibiofilm activity against MRSA, but their mechanism of action remains poorly understood. This study was designed to investigate the antibacterial and antibiofilm activities against MRSA of flavonoids identified from C. ambrosioides L. in combination with classic antibiotics, including ceftazidime, erythromycin, levofloxacin, penicillin G, and vancomycin. Liquid chromatography-mass spectrometry (LC-MS) was used to analyze the nonvolatile chemical compositions. Reverse transcription (RT)-PCR was used to investigate potential multitargets of flavonoids based on global transcriptional responses of virulence and antibiotic resistance. A synergistic antibacterial and biofilm-inhibiting activity of the alcoholic extract of the ear of C. ambrosioides L. in combination with penicillin G was observed against MRSA, which proved to be closely related to the interaction of the main components of kaempferol rhamnosides with quercetin. In regard to the mechanism, the increased sensitivity of MRSA to penicillin G was shown to be related to the downregulation of penicillinase with SarA as a potential drug target, while the antibiofilm activity was mainly related to downregulation of various virulence factors involved in the initial and mature stages of biofilm development, with SarA and/or σB as drug targets. This study provides a theoretical basis for further exploration of the medicinal activity of kaempferol rhamnosides and quercetin and their application in combination with penicillin G against MRSA biofilm infection.

Indexed as

Methicillin-Resistant Staphylococcus aureusAnti-Bacterial AgentsBiofilmsDown-RegulationFlavonoidsKaempferolsMicrobial Sensitivity TestsPenicillin ResistanceQuercetinAnti-Bacterial AgentsFlavonoidsKaempferolsQuercetinantibiotic resistancebiofilm formationChenopodium ambrosioides L.global regulationkaempferol rhamnosidesMRSAquercetinStaphylococcus aureus

Identifiers

PMID36354319
PMCPMC9769653
OpenAlexW4308687857

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.